Should Biotechnology Stock Black Diamond Therapeutics Inc (BDTX) Be in Your Portfolio Monday?

The 87 rating InvestorsObserver gives to Black Diamond Therapeutics Inc (BDTX) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 99 percent of stocks in the Biotechnology industry, BDTX’s 87 overall rating means the stock scores better than 87 percent of all stocks.

BDTX has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on BDTX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What’s Happening With Black Diamond Therapeutics Inc Stock Today?

Black Diamond Therapeutics Inc (BDTX) stock is down -5.69% while the S&P 500 has risen 0.02% as of 10:02 AM on Monday, Jul 3. BDTX has fallen -$0.29 from the previous closing price of $5.05 on volume of 434,132 shares. Over the past year the S&P 500 is up 16.18% while BDTX has risen 82.38%. BDTX lost -$2.38 per share the over the last 12 months.

Click Here to get the full Stock Report for Black Diamond Therapeutics Inc stock.